Speaker: Ruchir Trivedi, MD

Date: 06/12/2026

Time: 12:00 pm - 1:00 pm

Location: L-5040A- Dept of Medicine Conference Room

 

Session Attendance Code: NECDOB

 

Session Learning Objectives:  Participants will (be able to):

1.  Explain the physiology of sodium–glucose cotransport and its clinical implications in glucose homeostasis.

2.  Describe the mechanisms underlying the cardiorenal protective effects of SGLT2 inhibitors.

3.  Differentiate the on-target and off-target effects associated with SGLT2 inhibition in the kidney.

 

Speaker Disclosure Statement: Ruchir Trivedi, MD in their role as speaker for this educational event, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. There are no relevant financial relationships listed for this individual to be mitigated.  

 

Speaker Off-label Statement: Ruchir Trivedi, MD will not be discussing the off-labeled, or investigational use of any product or device. 

Target Audience: Scientists and Nephrologists throughout Connecticut, Medical House staff/Residents rotating through Nephrology services in Hartford Hospital, St. Francis Hospital, The Hospital of Central Connecticut and UCHC.

Accreditation: The University of Connecticut School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Connecticut School of Medicine designates this live activity for a maximum of _ 1 _ AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Conflict of Interest Policy: All faculty members participating in CME activities provided by the University of Connecticut School of Medicine are required to disclose to the program audience any actual or apparent conflict of interest related to the content of their presentations. Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content.

Activity Directors & Planning Committee Disclosure Statement: Neither the activity director, the activity administrator, nor the planning committee members in their role as planning committee members for this educational event, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. There are no relevant financial relationships listed for these individuals to be mitigated.

Commercial Support Statement: This CME activity has no commercial support associated with it.